Zhao Yun, Zhang Li-jiang, Wei Yan-qiu, Feng Yan-jun
Department of Obstetrics and Gynecology, People's Hospital, Beijing University, Beijing 100044, China.
Zhonghua Fu Chan Ke Za Zhi. 2003 Sep;38(9):538-40.
To study the changes of the thyroid hormones level of human fetus and newborns.
More than 71 cases of medically indicated cordocentesis have been done in 16 -36 gestational weeks in our hospital during last three years. Among them, 71 fetus who were free of diseases and their maternal thyroid function were normal were included into the study group. The blood samples were sent to analysis of thyroxine (T(4)), triiodothyroxine (T(3)), free thyroxine (FT(4)), free triiodothyroxine (FT(3)) and thyrotropin (TSH). 140 umbilical cord blood samples taken at the time of term delivery were sent to analysis of FT(4), FT(3) and TSH as a control. Normal range of different gestational weeks was calculated. Statistical analysis was done for the changes of all these thyroid hormones before 28 weeks and after.
All the thyroid hormones can be detected in 16 weeks of pregnancy, FT(4) already reaches the top level of adults (5.8 +/- 2.6) pmol/L and will continually increase with the increase of gestational age. There was a parallel increment of all the fetal thyroid hormone concentrations with the gestational age. The concentrations of T(4), T(3) and FT(4) have a rapidly increase after 28 weeks and have a statistically significant difference from (2.8 +/- 1.8) nmol/L, (37.2 +/- 27.2) nmol/L and (10.6 +/- 3.1) pmol/L, respectively to (5.8 +/- 2.6) nmol/L, (55.9 +/- 33.3) nmol/L, (13.0 +/- 4.5) pmol/L, respectively. TSH level of fetus was increased gradually along the gestation, reaching the up level of the adults at the 20 weeks and peaking at the birth time. While the T(3) and FT(3) keep in a lower level in gestation.
Fetal thyroid hormones increase with the gestational age. The diagnosis of congenital fetal thyroid hormone malfunction in the second half of the pregnancy should be monitored mainly by the T(4), FT(4) and TSH levels in different gestational age. For this consideration, to set up a reliable data for normal human fetus thyroid hormone concentrations is a very important and essential step to provide a practical guide for doctors to do intra-uterine diagnosis and treatment of associated high-risk groups. The peaking level of TSH at the birth time will surely company the changing of other thyroid hormones, so it might not be the best time to screening the congenital thyroid malfunction at the 72 hours after birth.
研究人类胎儿及新生儿甲状腺激素水平的变化。
在过去三年中,我院对16 - 36孕周进行医学指征性脐带穿刺术的71例以上孕妇进行了研究。其中,71例无疾病且其母亲甲状腺功能正常的胎儿被纳入研究组。采集血样检测甲状腺素(T₄)、三碘甲状腺原氨酸(T₃)、游离甲状腺素(FT₄)、游离三碘甲状腺原氨酸(FT₃)和促甲状腺激素(TSH)。选取140例足月分娩时采集的脐血样本检测FT₄、FT₃和TSH作为对照。计算不同孕周的正常范围。对28周前后所有这些甲状腺激素的变化进行统计分析。
妊娠16周时可检测到所有甲状腺激素,FT₄已达到成人的最高水平(5.8±2.6)pmol/L,并将随着孕周增加而持续升高。胎儿所有甲状腺激素浓度均随孕周平行增加。T₄、T₃和FT₄浓度在28周后迅速升高,分别从(2.8±1.8)nmol/L、(37.2±27.2)nmol/L和(10.6±3.1)pmol/L分别升高至(5.8±2.6)nmol/L、(55.9±33.3)nmol/L、(13.0±4.5)pmol/L,差异有统计学意义。胎儿TSH水平随孕周逐渐升高,在20周时达到成人上限,出生时达到峰值。而T₃和FT₃在孕期一直处于较低水平。
胎儿甲状腺激素随孕周增加。妊娠后半期先天性胎儿甲状腺激素功能异常的诊断应主要通过不同孕周的T₄、FT₄和TSH水平进行监测。基于此考虑,建立可靠的正常人类胎儿甲状腺激素浓度数据是为医生对相关高危人群进行宫内诊断和治疗提供实用指导的非常重要且必要的一步。出生时TSH的峰值肯定会伴随其他甲状腺激素的变化,因此出生后72小时可能不是筛查先天性甲状腺功能异常的最佳时间。